Barclays Initiates Coverage On Amrize with Equal-Weight Rating, Announces Price Target of $55

Benzinga Newsdesk www.benzinga.com Neutral 66.1%

Neg 0% Neu 66.1% Pos 0%

Barclays analyst Adam Seiden initiates coverage on Amrize (NYSE:AMRZ) with a Equal-Weight rating and announces Price Target of $55.